Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-29
2008-04-29
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S250000
Reexamination Certificate
active
07365078
ABSTRACT:
An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastral diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alpecia, irritable bowel syndrome, sleep disorders, dermatitides, schizophrenia, pain, etc. A triaza-cyclopenta[cd]indene derivative represented by the following formula [I]: has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved
REFERENCES:
patent: 6187781 (2001-02-01), Nakazato et al.
patent: 6600038 (2003-07-01), Nakazato et al.
patent: 6853732 (2005-02-01), Nakazato et al.
patent: 2005/0209253 (2005-09-01), Nakazato et al.
patent: 98/42699 (1998-01-01), None
patent: 2006/001511 (1998-01-01), None
patent: 00/53604 (2000-09-01), None
patent: WO 01/83486 (2001-11-01), None
patent: WO 01/87889 (2001-11-01), None
patent: 02/02549 (2002-01-01), None
patent: WO 02/094826 (2002-11-01), None
patent: 2004/058767 (2004-07-01), None
patent: 2005/066142 (2005-07-01), None
patent: 2005/066178 (2005-07-01), None
patent: 2005/066182 (2005-07-01), None
patent: 2005/085253 (2005-09-01), None
patent: 2006/001501 (2006-01-01), None
Bonamico, et al., Condensation Reactions of Tetracyanoethylene and its Monoanion Promoted by Lewis Acids: Synthesis and Crystal, Molecular, and Electronic Structure of a Novel Heterocycle, the 2, 3, 6, 7-Tetracyano-5-(tricyanoethenylimino)-3H-1,4,7b-triazabenzo[i,,j]pentalenide Ion, J. Chem. Soc. Perkin Trans. 2, 121-125 (1990).
Kennis Ludo E. J.
Nakazato Atsuro
Nozawa Dai
Okubo Taketoshi
Tamita Tomoko
Leeser Erich
Sughrue & Mion, PLLC
Taisho Pharmaceutical Co. Ltd.
Wilson James O.
LandOfFree
Triaza-cyclopenta[cd]indene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triaza-cyclopenta[cd]indene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triaza-cyclopenta[cd]indene derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2744498